Literature DB >> 5664316

A pilot trial of rifampicin in tuberculosis.

A Baronti, N Lukinovich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5664316     DOI: 10.1016/0041-3879(68)90020-2

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


× No keyword cloud information.
  6 in total

1.  A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.

Authors: 
Journal:  Pneumonologie       Date:  1975-12-12

Review 2.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease.

Authors:  P H Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 4.  Rifamycin antibiotics and the mechanisms of their failure.

Authors:  Rebekah A Adams; Gabrielle Leon; Natalia M Miller; Saira P Reyes; Chantal H Thantrong; Alina M Thokkadam; Annabel S Lemma; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal:  J Antibiot (Tokyo)       Date:  2021-08-16       Impact factor: 2.649

Review 5.  Rifampin.

Authors:  M Schonell; E Dorken; S Grzybowski
Journal:  Can Med Assoc J       Date:  1972-04-08       Impact factor: 8.262

Review 6.  All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era.

Authors:  Helen R Stagg; Mary Flook; Antal Martinecz; Karina Kielmann; Pia Abel Zur Wiesch; Aaron S Karat; Marc C I Lipman; Derek J Sloan; Elizabeth F Walker; Katherine L Fielding
Journal:  ERJ Open Res       Date:  2020-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.